Eastwest Partners with CrossDock Systems for Product Warehousing and Shipping Solutions

EastWest continues expansion across Canada, partnering with one of Canada's fastest growing full-service logistics solutions provider for Eastern Canadian distribution

VANCOUVER, BC / ACCESSWIRE / November 26, 2018 / Harbour Star Capital Corp. dba EastWest Bioscience (the "Company" or "EastWest") EAST announces that it is building its distribution channel in Eastern Canada by partnering with Crossdock Systems, a premier full service logistics solutions provider located in Mississauga, ON. Crossdock Systems allows for EastWest products to be warehoused and shipped to customers from Mississauga, Ontario for all its Eastern Canadian customers. With purchase orders continuing to grow, and additional SKU's planned for launch in 1Q 2019, it is a critical logistics step for EastWest. By partnering with Crossdock Systems, EastWest will now be able to warehouse inventory both in their own Penticton, BC facility and at Crossdock Systems Eastern Canada, allowing for faster product turn around as well as significant shipping savings, which go right to the bottom line.

Crossdock systems operates a state-of-the-art warehouse in Mississauga, Ontario, with a fleet of trucks in the Greater Toronto Area, and an expanding network of carriers that ship throughout North America. Crossdock Systems has been building a reputation as a premier full-service logistics solutions provider for almost 20 years, and currently works with some of the largest manufacturers, retailers, and municipalities in Canada.

"It has always been our plan to mirror our fulfillment success in Western Canada to Eastern Canada, where the bulk of our customers and orders come from. This partnership with a leading partner like Crossdock, will allow us to not only ensure quicker order fulfillment to our Eastern Canadian customers, but add significant savings to our shipping costs." says Rodney Gelineau, EastWest BioScience CEO. "Crossdock Systems knows their customer's businesses as much as their own, and they are a fantastic partner to work with in Eastern Canada and give us the ability to scale anywhere in North America."

About Crossdock Systems

Founded in 2000, Crossdock systems continues to grow as a premier full-service logistics solutions provider out of their state-of-the-art warehouse in Ontario Canada. Crossdock operates a fleet of trucks in Metropolitan Toronto and arranges freight movements across North America with their ever-expanding network of carriers. Crossdock systems has been featured twice on PROFIT magazine's list of the fastest growing companies in Canada. Crossdock Systems offers a full-service solution to its customers, be it local deliveries, cross-border shipments, and major distribution programs.

About EastWest BioScience Group

EastWest Bioscience is a seed-to-sale organization that offers world class manufacturing and premium hemp-based consumer goods. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium hemp products. EastWest is strategically positioned in mainstream consumer markets with wholistic natural products and has developed distribution channels into mainstream stores and markets in Canada. The Company has a Health Canada licensed, GMP (Good Manufacturing Practices) certified manufacturing facility and produces premium brands offering natural products for a preventive care lifestyle. EastWest consumer product lines are divided into four distinct brands: 1) Natural Advancement - natural biopharmaceutical health supplements; 2) Earth's Menu - all-natural hemp superfoods; 3) Natural Pet Science - pet food and pet supplements; and 4) Chanvre Hemp -all-natural health and beauty products. The organization will continue to focus on ongoing development of innovative, hemp-based consumer products through advanced science with clean, natural ingredients to complement its current product offerings.

ON BEHALF OF THE BOARD OF DIRECTORS
EASTWEST BIOSCIENCE GROUP

"Rodney Gelineau"
Co-Founder, Chief Executive Officer and Director

For further information, please visit www.eastwestbioscience.com or contact EastWest Bioscience representatives at 1-800-409-1930 or investors@eastwestscience.com.

This press release is not an offer of securities for sale in the United States. The securities described in this press release have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the U.S. Securities Act of 1933, as amended) absent registration or an exemption from registration. This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction where such offer, solicitation, or sale would be unlawful.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the terms and conditions of the Acquisition. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: EastWest Bioscience